INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 10 | -23.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 13 | -92.1% | 0.00% | – |
| Q2 2021 | $3,000 | -88.0% | 165 | -84.9% | 0.00% | – |
| Q1 2021 | $25,000 | +525.0% | 1,096 | +564.2% | 0.00% | – |
| Q4 2020 | $4,000 | -42.9% | 165 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -12.5% | 165 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -57.9% | 165 | -41.1% | 0.00% | -100.0% |
| Q3 2019 | $19,000 | +216.7% | 280 | +460.0% | 0.00% | – |
| Q3 2018 | $6,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |